Status:
COMPLETED
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
Lead Sponsor:
AstraZeneca
Conditions:
Uncomplicated Peptic Ulcer
Eligibility:
All Genders
50-84 years
Brief Summary
This study is conducted in a cohort of low dose aspirin (ASA) users previously ascertained. The aims of the post hoc analyses are: To estimate the incidence of uncomplicated peptic ulcer (UPU) in a c...
Detailed Description
The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users
Eligibility Criteria
Inclusion
- \- Patients aged 50-84 years in 2000-2007 with a first prescription of low dose ASA ( see study population description)
Exclusion
- \- Patients aged below age 50 and 85 years and above ( see study population description)
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
39000 Patients enrolled
Trial Details
Trial ID
NCT01814943
Start Date
November 1 2012
End Date
May 1 2013
Last Update
June 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Madrid, Spain